REM Results Bearish
REMGRO LIMITED - Summary of Mediclinic Holdings Limited results for the year ended 31 March 2026
Remgro Limited
Free preview
What this filing means
Remgro's voluntary disclosure of Mediclinic's FY26 results reveals a $733m net loss driven by massive Swiss impairments, overshadowing a 45% increase in adjusted operating earnings.
Bull case
- Adjusted EBITDA grew by 14% to $842m, with the EBITDA margin expanding to 15.7% supported by revenue growth and cost efficiencies.
- Balance sheet discipline improved, with the leverage ratio reducing to 2.7x from 3.1x and cash conversion strengthening to 106%.
Bear case
- Headline growth was significantly flattered by currency translation, as adjusted revenue growth of 11% drops to only 5% in constant currency terms.
View original SENS announcement
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
Unlock the full analysis
Free during launch. Sign in to read the complete breakdown.
- Full bull / bear breakdown
- Decision framework
- Citations & sources
- Price autopsy
More on Remgro Limited
Related filings
More from REM
- REMGRO LIMITED - Completion of disposal of shares held in FirstRand Limited
- REMGRO LIMITED - Dealings in securities by an executive director
- REMGRO LIMITED - Dealings in securities by executive directors, prescribed officers and the company secretary
- REMGRO LIMITED - Acceptance of awards by executive directors, prescribed officers and company secretary
- REMGRO LIMITED - Restructuring of interests in Mediclinic Holdings and withdrawal of cautionary announcement
Other Results
- XIINUMERAL LIMITED - Updated Short Form SENS Announcement - Summary of the Audited Financial Statements for the year ended 28 February 26
- XIINUMERAL LIMITED - Updated Short Form SENS Announcement _Summary of the Audited Financial Statements for the year ended 28 February 26
- XIINUMERAL LIMITED - CANCELLATION OF S524165 SF: Summary of the Audited Financial Statements for the Year Ended 28 February 2026
- XIINUMERAL LIMITED - SF: Summary of the Audited Financial Statements for the Year Ended 28 February 2026
- SLGSALUNGANO GROUP LIMITED - Audited Consolidated Financial Results for the Year ended 31 March 2026